ABVC BioPharma Ownership 2024 | Who Owns ABVC BioPharma Now?
Institutional Ownership
1.78%
Insider Ownership
22.93%
Retail Ownership
75.29%
Institutional Holders
8.00
ABVC BioPharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -129 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -18,421 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -22,101 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -139,282 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -5,814 | -100.00% | - | Sep 30, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -13,879 | -100.00% | - | Sep 30, 2023 |
SPOTLIGHT ASSET GROUP, INC. | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
ABVC BioPharma's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -129 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -18,421 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -22,101 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -139,282 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -5,814 | -100.00% | - | Sep 30, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -13,879 | -100.00% | - | Sep 30, 2023 |
SPOTLIGHT ASSET GROUP, INC. | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
The largest ABVC BioPharma shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of ABVC BioPharma (ABVC), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -129 | -100.00% | - | Sep 30, 2023 |
SPOTLIGHT ASSET GROUP, INC. | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -5,814 | -100.00% | - | Sep 30, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -13,879 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -18,421 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -22,101 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -139,282 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, ABVC BioPharma's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.13K stocks of ABVC, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -139,282 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -22,101 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -18,421 | -100.00% | - | Sep 30, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -13,879 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -5,814 | -100.00% | - | Sep 30, 2023 |
SPOTLIGHT ASSET GROUP, INC. | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -129 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, ABVC BioPharma's biggest institutional seller is GEODE CAPITAL MANAGEMENT, LLC. The company sold -0.14M shares of ABVC, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -139,282 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -22,101 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -18,421 | -100.00% | - | Sep 30, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -13,879 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -5,814 | -100.00% | - | Sep 30, 2023 |
SPOTLIGHT ASSET GROUP, INC. | - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -129 | -100.00% | - | Sep 30, 2023 |
ABVC BioPharma's largest sold out institutional shareholder by shares sold is GEODE CAPITAL MANAGEMENT, LLC, sold -0.14M shares, valued at -, as of undefined.
ABVC BioPharma Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD INDEX FUNDS | 0.00% | 387,513 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 137,699 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 46,947 | -7,547 | -13.85% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 22,000 | 2,520 | 12.94% | Feb 29, 2024 |
iSHARES TRUST | 0.00% | 11,876 | - | - | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 751 | - | - | Mar 31, 2024 |
ABVC BioPharma's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 387.51K shares, compromising 0.00% of its total assets.
ABVC BioPharma Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 23 | 8 | -11.11% |
31 Mar, 23 | 9 | - |
31 Dec, 22 | 9 | - |
30 Sep, 22 | 9 | 80.00% |
30 Jun, 22 | 5 | 25.00% |
31 Mar, 22 | 4 | -20.00% |
31 Dec, 21 | 5 | -44.44% |
30 Sep, 21 | 9 | - |
As of 30 Jun 23, 8 institutions are holding ABVC BioPharma's shares, representing a decrease of -11.11% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 23 | 588,139 | -11.04% |
31 Mar, 23 | 661,135 | 9.61% |
31 Dec, 22 | 603,148 | -7.25% |
30 Sep, 22 | 650,266 | -58.39% |
30 Jun, 22 | 1,562,841 | 265.33% |
31 Mar, 22 | 427,791 | -6.81% |
31 Dec, 21 | 459,042 | 103.20% |
30 Sep, 21 | 225,904 | - |
ABVC BioPharma (ABVC) has 588.14K shares outstanding as of 30 Jun 23, down -11.04% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 23 | 1.78% | 44.51% |
31 Mar, 23 | 2.00% | 55.09% |
31 Dec, 22 | 1.90% | 47.80% |
30 Sep, 22 | 2.00% | 8.01% |
30 Jun, 22 | 4.99% | 240.34% |
31 Mar, 22 | 1.44% | 42.93% |
31 Dec, 21 | 1.83% | 259.47% |
30 Sep, 21 | 0.84% | - |
As of 30 Jun 23, ABVC BioPharma is held by 1.78% institutional shareholders, representing a 44.51% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 23 | 3 | -50.00% |
31 Mar, 23 | 6 | 20.00% |
31 Dec, 22 | 5 | -28.57% |
30 Sep, 22 | 7 | 133.33% |
30 Jun, 22 | 3 | 200.00% |
31 Mar, 22 | 1 | -75.00% |
31 Dec, 21 | 4 | -55.56% |
30 Sep, 21 | 9 | - |
3 institutional shareholders have increased their position in ABVC stock as of 30 Jun 23 compared to 6 in the previous quarter (a -50.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 23 | 2 | 100.00% |
31 Mar, 23 | 1 | -66.67% |
31 Dec, 22 | 3 | 200.00% |
30 Sep, 22 | 1 | - |
30 Jun, 22 | - | -100.00% |
31 Mar, 22 | 2 | - |
31 Dec, 21 | - | - |
30 Sep, 21 | - | - |
2 institutional shareholders have reduced their position in ABVC stock as of 30 Jun 23 compared to 1 in the previous quarter (a 100.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 23 | 8 | -11.11% | 588,139 | -11.04% | 1.78% | 44.51% | 3 | -50.00% | 2 | 100.00% |
31 Mar, 23 | 9 | - | 661,135 | 9.61% | 2.00% | 55.09% | 6 | 20.00% | 1 | -66.67% |
31 Dec, 22 | 9 | - | 603,148 | -7.25% | 1.90% | 47.80% | 5 | -28.57% | 3 | 200.00% |
30 Sep, 22 | 9 | 80.00% | 650,266 | -58.39% | 2.00% | 8.01% | 7 | 133.33% | 1 | - |
30 Jun, 22 | 5 | 25.00% | 1,562,841 | 265.33% | 4.99% | 240.34% | 3 | 200.00% | - | -100.00% |
31 Mar, 22 | 4 | -20.00% | 427,791 | -6.81% | 1.44% | 42.93% | 1 | -75.00% | 2 | - |
31 Dec, 21 | 5 | -44.44% | 459,042 | 103.20% | 1.83% | 259.47% | 4 | -55.56% | - | - |
30 Sep, 21 | 9 | - | 225,904 | - | 0.84% | - | 9 | - | - | - |
ABVC BioPharma Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of ABVC BioPharma's stock was made by An Chihliang on Mar 31 2022, selling - shares at - per share (valued at -).
ABVC BioPharma Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2022 | - | - | - |
Q4 2021 | - | - | - |
Q3 2021 | - | 6 | - |
Q3 2015 | - | 1 | - |
Q1 2012 | 1 | 1 | 100.00% |
Q3 2011 | - | 3 | - |
Q2 2011 | 5 | 1 | 500.00% |
Q3 2010 | 1 | 1 | 100.00% |
Q2 2010 | 1 | - | - |
Q1 2010 | 3 | - | - |
Q4 2009 | 4 | - | - |
Q3 2009 | 5 | 10 | 50.00% |
Q2 2009 | 7 | 2 | 350.00% |
Q1 2009 | 17 | 2 | 850.00% |
Q4 2008 | 3 | 1 | 300.00% |
Q3 2008 | 5 | 1 | 500.00% |
Q2 2008 | 5 | - | - |
Q1 2008 | - | 5 | - |
Q3 2007 | 1 | 5 | 20.00% |
Q2 2007 | - | - | - |
0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by ABVC BioPharma's insiders, as of Q2 2022.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2022 | - | - | - |
Q4 2021 | - | - | - |
Q3 2021 | - | - | - |
Q3 2015 | - | - | - |
Q1 2012 | - | - | - |
Q3 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2010 | - | - | - |
Q2 2010 | 1 | - | - |
Q1 2010 | 2 | - | - |
Q4 2009 | 4 | - | - |
Q3 2009 | 2 | - | - |
Q2 2009 | 7 | - | - |
Q1 2009 | 16 | 2 | 800.00% |
Q4 2008 | - | - | - |
Q3 2008 | 4 | 1 | 400.00% |
Q2 2008 | - | - | - |
Q1 2008 | - | - | - |
Q3 2007 | 1 | - | - |
Q2 2007 | - | - | - |
As of Q2 2022, Insider owners conducted 0 open market buy trades and 0 open market sell trades of ABVC BioPharma's stocks.
ABVC BioPharma Peer Ownership
Ticker | Company |
---|---|
MGTA | Dianthus Therapeutics, Inc. |
ARDS | Aridis Pharmaceuticals, Inc. |
NTRB | Nutriband Inc. |
MNPR | Monopar Therapeutics Inc. |
SABS | SAB Biotherapeutics, Inc. |
KTTA | Pasithea Therapeutics Corp. |
LGVN | Longeveron Inc. |
ADTX | Aditxt, Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
APTX | Aptinyx Inc. |
EVLO | Evelo Biosciences, Inc. |
AKTX | Akari Therapeutics, Plc |
VRAX | Virax Biolabs Group Limited |
ELDN | Eledon Pharmaceuticals, Inc. |
RNXT | RenovoRx, Inc. |
INDP | Indaptus Therapeutics, Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
ACST | Acasti Pharma Inc. |
ALRN | Aileron Therapeutics, Inc. |
FBRX | Forte Biosciences, Inc. |
ABVC Ownership FAQ
Who Owns ABVC BioPharma?
ABVC BioPharma is owned by institutional shareholders (1.78%), insiders (22.93%), and public (75.29%). The largest institutional shareholder of ABVC BioPharma is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).
Who are the major institutional shareholders of ABVC BioPharma?
ABVC BioPharma's major institutional shareholders are WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, TWO SIGMA INVESTMENTS, LP, GEODE CAPITAL MANAGEMENT, LLC, and BLACKROCK INC.. The top five shareholders own together 0% of the company's share outstanding.
How many ABVC BioPharma shareholders are there?
As of Jun 2023, there are 8 institutional shareholders of ABVC BioPharma.
What percentage of ABVC BioPharma is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN owns 0 shares of ABVC BioPharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).
What percentage of ABVC BioPharma is owned by NORTHERN TRUST CORP?
As of Sep 2023, NORTHERN TRUST CORP holds 0 shares of ABVC BioPharma (ABVC), compromising 0% of the company, valued at $0.
What percentage of ABVC BioPharma is owned by TWO SIGMA INVESTMENTS, LP?
TWO SIGMA INVESTMENTS, LP is the third largest holder of ABVC BioPharma. The company owns 0 of the company's shares outstanding (worth $0).